Sen. Grassley comments on nomination of Douglas H. Shulman for IRS commissioner
U.S. Sen. Chuck Grassley of Iowa issued the comment below about the announcement made today by the White House that the President intends to nominate Douglas H. Shulman to be Commissioner of Internal Revenue at the Department of the Treasury. “The position of IRS commissioner is critical and shouldn’t be vacant at all. At least […]
Summary of Sen. Grassley’s Non-profit Oversight to Date
SUMMARY OF SEN. CHUCK GRASSLEY’S NON-PROFIT OVERSIGHTNovember 20, 2007 INTRODUCTION For the last five years, Sen. Chuck Grassley, Iowa Republican, has reviewed and worked to reformvarious shortcomings and abuses in the tax-exempt arena, as well as worked to increase charitablegiving incentives. His goals are to ensure that non-profits are protected from money-makingopportunists; that donors feel […]
Grassley, Baucus seek information from former drug company executive in Avandia case
WASHINGTON — Sens. Chuck Grassley and Max Baucus have asked a former drug company research executive to provide information to the Senate Committee on Finance about attempts to intimidate a prominent independent scientist who voiced concerns about drug safety. Dr. Tadataka Yamada was formerly the head of research at GlaxoSmithKline. He now heads the Global […]
Summary of Sen. Grassley’s Non-profit Oversight to Date
INTRODUCTION For the last five years, Sen. Chuck Grassley, Iowa Republican, has reviewed and worked to reform various shortcomings and abuses in the tax-exempt arena, as well as worked to increase charitable giving incentives. His goals are to ensure that non-profits are protected from money-making opportunists; that donors feel confident that their money is well-spent; […]
Sen. Grassley applauds CMS, urges agency to keep up efforts to safeguard Medicare dollars
WASHINGTON — Sen. Chuck Grassley praised the Centers for Medicare and Medicaid Services today for the reduction in improper Medicare payments over the last year. “I never shy away from riding herd on the Centers for Medicare and Medicaid Services because of Congress’ responsibility to conduct oversight and the obligation of the federal bureaucracy to […]
Senators Seek To Prohibit Patenting Of Tax Strategies
Washington, DC– Senate Finance Committee Chairman Max Baucus (D-Mont.) and Ranking Republican Member Chuck Grassley (R-Iowa) today introduced legislation to prohibit the Patent and Trademark Office (PTO) from granting patents for common tax strategies and tax planning inventions. To date, the PTO has granted 60 tax patents, with 99 pending final decisions. This measure seeks […]
Sen. Grassley’s floor statement regarding the intimidation of scientists in drug-safety deliberations
Mr. President, just about three years ago on November 18, 2004, I convened a hearing on the worldwide withdrawal of Vioxx, a blockbuster pain medication. That hearing turned the spotlight on systemic problems at the Food and Drug Administration.We found that the FDA maintained a cozy relationship with the drug industry and suppressed scientific dissent […]
Grassley: IRS Says Virgin Islands Tax Change Would Hurt Tax Compliance Effort
In May, Sen. Chuck Grassley, ranking member of the Committee on Finance, asked the IRS to evaluate the tax compliance impact of a proposal to change the statute of limitations for civil tax cases involving individuals claiming residency in the U.S. Virgin Islands. The House has passed legislation to make that change, and the Senate […]
Sen. Grassley’s statement at news conference on the Alternative Minimum Tax
Last Friday, November 9th, the House passed the Temporary Tax Relief Act of 2007. The purpose of the bill was to offer an AMT “patch” and extend certain expiring tax provisions. The House-passed bill was designed to prevent an AMT increase for at least 19 million families. While this action is six months later than […]
Sen. Grassley comments on new black box warning for heart attacks on widely used diabetes drug
Sen. Chuck Grassley issued the comment below about the decision announced today by the Food and Drug Administration to add a new warning to the existing black box on the diabetes drug Avandia. The new warning concerns the drug’s risk for heart attacks. The FDA first applied a black box to Avandia in August concerning […]